Cargando…
Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
Tamoxifen (TAM), a selective estrogen receptor modulator, is often used for long-term adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer. TAM is known to increase the risk of endometrial cancer (EC); however, the mechanism has not yet been fully elucidated. Therefore...
Autores principales: | Saeki, Harumi, Horimoto, Yoshiya, Hlaing, May Thinzar, Men, Yuan, Rong, Lu, Ishizuka, Yumiko, Uomori, Toshitaka, Yoshida, Emiko, Terao, Yasuhisa, Arakawa, Atsushi, Saito, Tsuyoshi, Yao, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688500/ https://www.ncbi.nlm.nih.gov/pubmed/38034487 http://dx.doi.org/10.3892/ol.2023.14142 |
Ejemplares similares
-
Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin
por: Hlaing, May Thinzar, et al.
Publicado: (2022) -
Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer
por: Shikanai, Ayana, et al.
Publicado: (2022) -
Acute myocarditis during adjuvant therapies for breast cancer: a case report
por: Ushiyama, Yumiko, et al.
Publicado: (2023) -
Clinicopathological Examination of Metaplastic Spindle Cell Carcinoma of the Breast: Case Series
por: Ishizuka, Yumiko, et al.
Publicado: (2021) -
Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2020)